Food Peptides, Gut Microbiota Modulation, and Antihypertensive Effects

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 24; p. 8806
• Main Authors: Tsafack, Patrick Blondin, Li, Chen, Tsopmo, Apollinaire
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.12.2022; MDPI
• Subjects: Amines; Analysis; Angiotensin; Animal models; Animals; Antibiotics; Antihypertensive Agents - pharmacology; Antihypertensive Agents - therapeutic use; Antihypertensives; Bacteria; Bile acids; Biogenic amines; Blood pressure; Carbohydrates; Cardiovascular diseases; Chronic illnesses; Complex systems; Diabetes; Diet; Disease; Dysbacteriosis; Endothelium; Enzymes; Fatty acids; Food; food peptides; Gastrointestinal Microbiome; Humans; Hypertension; Hypoxia; Immune system; Inflammation; Inflammation - drug therapy; Inheritances; Intestinal microflora; Metabolic disorders; Metabolism; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Oxidative stress; Peptides; Peptides - pharmacology; Peptides - therapeutic use; Permeability; Physiology; Polysaccharides; Prebiotics; Proteins; Renin; Review; Saccharides; Taxonomy; microbiota; food peptides; inflammation; hypertension
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27248806

The gut microbiota is increasingly important in the overall human health and as such, it is a target in the search of novel strategies for the management of metabolic disorders including blood pressure, and cardiovascular diseases. The link between microbiota and hypertension is complex and this review is intended to provide an overview of the mechanism including the production of postbiotics, mitigation of inflammation, and the integration of food biological molecules within this complex system. The focus is on hydrolyzed food proteins and peptides which are less commonly investigated for prebiotic properties. The analysis of available data showed that food peptides are multifunctional and can prevent gut dysbiosis by positively affecting the production of postbiotics or gut metabolites (short-chain fatty acids, polysaccharides, biogenic amines, bile acids). Peptides and the postbiotics then displayed antihypertensive effects via the renin-angiotensin system, the gut barrier, the endothelium, and reduction in inflammation and oxidative stress. Despite the promising antihypertensive effect of the food peptides via the modulation of the gut, there is a lack of human studies as most of the works have been conducted in animal models.